Clinical Trials Logo

Other clinical trials

View clinical trials related to Other.

Filter by:

NCT ID: NCT04598425 Completed - Insomnia Clinical Trials

Cognitive Behavioral Therapy for Insomnia (CBTi) in Patients With Mental Illness

Start date: August 1, 2018
Phase: N/A
Study type: Interventional

Insomnia is common in patients with co-morbid mental illness and sleeping difficulties is a frequent complaint in most psychological disorders. Mental illness may cause sleep problems, however, sleep problems like insomnia, may also cause or exacerbate mental illness. Insomnia may aggravate symptoms of depression, anxiety and fatigue, and reduce daily functioning in patients with co-morbid insomnia and mental illness. This project aims to evaluate a course offered to patients with insomnia and mental illness at Diakonhjemmet Hospital. The course is based on cognitive behavioral therapy, a documented treatment for insomnia.

NCT ID: NCT04598386 Completed - Cognitive Change Clinical Trials

The Effect of AMP Human Sodium Bicarbonate Lotion on Hydration

AMPlify
Start date: December 9, 2020
Phase: N/A
Study type: Interventional

The purpose of this research study is to evaluate the effects of a topical sodium bicarbonate lotion on physiological and psychological responses associated with hydration status and fluid balance in humans during passive heat stress. Currently, the ingestion of sodium has been an effective measure for improvements in fluid regulation and hydration status in humans. However, the investigators do not know its regulatory relationship with measurements of fluid balance when supplemented through the skin.

NCT ID: NCT04598178 Completed - Clinical trials for Postoperative Cognitive Dysfunction

Normative Data for the Qmci-TW in a Taiwanese Sample

Start date: August 4, 2020
Phase:
Study type: Observational

Many perioperative factors have been pointed out as the risk factors for postoperative cognitive dysfunction, which may occur immediately after the surgery, days after the surgery, or months after the surgery. Quick mild cognitive impairment screen (Qmci) is a sensitive and specific test to differentiate mild postoperative cognitive dysfunction. However, the learning effect have been raised as a bias when we repeated the same test for one person at different timing. Thus the study is designed to collected the Normative Data in series for the Qmci-TW in a Taiwanese Sample.

NCT ID: NCT04597814 Completed - Clinical trials for the Relationship Between the Tumor Markers and Interstitial Lung Disease Patients

The Relationship Between the Tumor Markers and Interstitial Lung Disease

Start date: January 1, 2019
Phase:
Study type: Observational

The serum levels of carcinoembryonic antigen (CEA), carbohydrate antigen 19-9 (CA19-9), CA125 are often increased in interstitial lung disease patients. This study was undertaken to investigate the source of these serum tumor markers.

NCT ID: NCT04597632 Completed - Clinical trials for Neovascular Age-related Macular Degeneration

An Extension Study Assessing the Efficacy and Safety of Brolucizumab in a Treat-to-Control Regimen in Patients With Neovascular Age-related Macular Degeneration Who Have Completed the CRTH258A2303 (TALON) Study

TALON Ext
Start date: December 16, 2020
Phase: Phase 3
Study type: Interventional

The purpose of this extension study was to evaluate the efficacy and safety of brolucizumab used in a Treat-to-Control-regimen for treatment of patients with neovascular age-related macular degeneration who have completed the CRTH258A2303 (TALON) study. The main objective was to assess brolucizumab's potential for long durability up to 20 weeks. All eligible participants were treated with brolucizumab regardless of their treatment in the TALON study. The study period was 56 weeks including post-treatment follow-up.

NCT ID: NCT04597606 Completed - Clinical trials for Pulmonary Disease, Chronic Obstructive

Respiratory Drive Response in COPD Patients During Exercise With Non Invasive Ventilation (NIV).

HFNIV
Start date: September 2, 2019
Phase:
Study type: Observational

A constant load exercise during 10 minutes will be performed in a group of Chronic Obstructive Pulmonary Disease patients, in a basal condition (spontaneous breathing); under noninvasive mask ventilation and with high flow nasal cannula. With the aim of reducing dyspnea, increasing exercise tolerance, and unload respiratory muscles, three exercises will be compared in terms of use of respiratory muscles and neural drive measured with paraesternal electromyography.

NCT ID: NCT04597593 Completed - Clinical trials for Drug-Related Side Effects and Adverse Reactions

Association Between Genetic Variant Scores and DOACs (DARES2)

Start date: October 7, 2020
Phase:
Study type: Observational

The study's objective is to evaluate the predictive accuracy of Cipherome's algorithm in predicting and preventing serious adverse drug reactions (ADRs) experienced by patients while on direct oral anti-coagulants (DOACs).

NCT ID: NCT04597333 Completed - Clinical trials for Induction of Labor Affected Fetus / Newborn

Labor Induction After Failed Induction With Dinoprostone.

Start date: October 15, 2020
Phase: N/A
Study type: Interventional

Women after induction of labor with a dinoprostone insert will be evaluated after 24 hours from the beginning of labor induction. Women with a BISHOP score of less than 5 will be randomized to 1 of 2 groups. Induction with a cervical ripening balloon versus induction with a 2nd dinoprostone insert.

NCT ID: NCT04597151 Completed - Clinical trials for Stage IV Colorectal Cancer AJCC v8

Diet Education Program for Stage I-IV Colorectal Cancer Survivors

Start date: October 12, 2020
Phase: N/A
Study type: Interventional

This pilot trial evaluates the feasibility of a group diet education program for stage I-IV colorectal cancer survivors. Providing a nutrition education program for colon and rectal cancer survivors may help them have better access to the tools necessary to make healthy food decisions that can impact their cancer outcomes.

NCT ID: NCT04597073 Completed - Gingivitis Clinical Trials

Measurement of Oncostatin M, Leukemia Inhibitory Factor and Interleukin-11 Levels of Patients With Periodontal Disease

Start date: March 2014
Phase: N/A
Study type: Interventional

This study aims to determine Oncostatin M (OSM), Leukemia inhibitory factor (LIF), and Interleukin-11 (IL-11) levels in gingival crevicular fluid (GCF), saliva, and serum in periodontally healthy individuals and those with gingivitis and chronic periodontitis before and after periodontal treatment and to evaluate the relationship between these cytokine levels and clinical periodontal parameters.